First, in spite of having “only” moderate to severe mitral regurgitation, these patients with HF were quite advanced, as evidenced by their high baseline natriuretic peptide levels, poor NYHA ...

We conducted a randomized, controlled trial involving patients with heart failure and moderate to severe functional mitral regurgitation from 30 sites in nine countries. The patients were assigned ...

At 30 days, a group of 15 patients who underwent transfemoral transcatheter mitral valve replacement for moderate to severe mitral regurgitation had no deaths, strokes, reinterventions or new ...

Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to ...